GxP news - QFINITY
QFINITY · News · Insights & Events

Shaping the regulated quality of tomorrow.

Articles and analysis from our own work across GxP, pharma, quality management, GAMP and AI - what is changing in the regulated environment, what it means in practice, and what is happening inside our company.

Latest articles

Events, case studies and insights.

Steering Committee am Konferenztisch, goldene Lichtlinie als entstehendes Programm - 4. ACDM KI Symposium

We are very pleased that QFINITY Qualitätsmanagement was represented on the Steering Committee of the 4th Annual Symposium on Artificial Intelligence in Clinical Trials hosted by the ACDM (Association for Clinical Data Management).

Our colleague Marcus Schwabedissen helped shape the program for this major industry event, together with five fellow experts from leading companies:

– Ashley Howard, Pfizer
– Tim Armitage, Medidata Solutions
– Marcus Schwabedissen, QFINITY Qualitätsmanagement
– Rob Nichols, Coronado Research
– Richard Davies, CluePoints
– Robert King, Thermo Fisher Scientific

The Steering Committee curated a strong, forward-looking program with great dedication and expertise, bringing together leading minds from industry, research, and technology to discuss the current state and future of artificial intelligence in clinical trials.

We thank the ACDM for its trust and for the opportunity to play an active part in shaping the symposium – and we look forward to more initiatives around AI and clinical data management.

Titelbild zum Beitrag: QFINITY bei der SAP & Partners Expert Serie

On May 27, Oliver Herrmann, Managing Director of QFINITY, spoke at the third session of the SAP & Partners Expert Series for Life Sciences. The event focused on one of the key challenges in regulated GxP environments: how to drive innovation without losing sight of compliance.

His presentation centered on one theme: Innovation through modern quality assurance.

In his talk, Mr. Herrmann shared practical approaches that help life sciences companies leverage innovative technologies while still meeting strict regulatory requirements.

Key topics included:

  • The role of Computer Software Assurance (CSA) in fostering critical thinking and modern quality approaches

  • Iterative and incremental methods for meeting compliance requirements

  • Hands-on insights into dealing with CSV requirements and cloud-based solutions

This session was part of a ten-part series specifically designed for companies in life sciences, pharmaceuticals, and medical technology.

You can watch the session recording here:
https://lnkd.in/evupNNxG

Explore the full Expert Series and register here:
https://lnkd.in/evupNNxG

We’re proud to have been part of the SAP & Partners Expert Series.

Event banner: 4th ACDM AI Symposium | June 23-24, 2025

4th ACDM AI SymposiumOn June 23-24, 2025, Marcus Schwabedissen, COO of QFINITY, will participate in the 4th ACDM AI Symposium in Frankfurt. This event brings together international experts in clinical data science to discuss current developments, practical applications, and the regulatory and ethical challenges of using artificial intelligence (AI) in clinical research.

As a long-standing active member of the ACDM and a member of the Steering Committee, Marcus Schwabedissen plays a key role in shaping the strategic direction of the symposium. With his extensive experience in optimizing clinical data management processes and implementing innovative technologies, he provides valuable input on the quality-driven, forward-looking use of AI in data-driven healthcare.

His participation highlights QFINITY’s ongoing commitment to innovation, quality, and practical advancement in clinical research.

You can find more information about the 4th ACDM AI Symposium here.